Harish Adoni has a background in cancer biology and the tumor microenvironment. He trained at the University of Texas MD Anderson Cancer Center and subsequently transitioned to developing cell and gene therapies. Over the last decade, Harish has enjoyed the privilege of working on analytical method development and validation for Abecma and development of cell-based assays for investigational therapies at Unum Therapeutics and ElevateBio. He uses his expertise in assay development, flow cytometry and rare cell isolation to bring novel therapeutics to patients in need.